2 ms·
This may not actually hurt the profits of the drug industry, because they would probably renegotiate their prices with the other countries. Right now, as long a
by RcouF1uZ4gsC 10y ago
This may not actually hurt the profits of the drug industry, because they would probably renegotiate their prices with the other countries. Right now, as long as the cost of what they charge to country is basically their marginal cost of production, they don't have much incentive to oppose the negotiation. Now, they can say that because they have to charge the same to the US, the other countries will have to pay more, or not get the drug. Thus, this has the potential to be revenue neutral for the drug companies while spreading out the cost more fairly